Safety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow up

@inproceedings{Bhasin2017SafetyAF,
  title={Safety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow up},
  author={Ashu Bhasin and S. Senthil Kumaran and Rohit Bhatia and Sujata Mohanty and M. V. Padma Srivastava},
  booktitle={Journal of stem cells & regenerative medicine},
  year={2017}
}
Introduction: Stem cell (SC) therapy has been envisioned as a therapeutic vehicle to promote recovery in resistant neurological diseases. Knowing the logistics and paradigms in recovery processes after Stroke, clinicians have pioneered the transplantation therapy. This study presents four-year follow up of our previous trial transplanting bone-marrow-derived animal-free culture expanded intravenous mesenchymal stem cells (MSCs) in chronic stroke which was published in 2010. Methods: We… CONTINUE READING
3 Citations
40 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 40 references

The rise of Cell Therapy trials of Stroke

  • P Castro Henrique, P Coehlo Pimentel, M Fonseca, GR Freitas, RM. Otero
  • Review of Registered and published studies. Stem…
  • 2013
1 Excerpt

The rise of Cell Therapy trials of Stroke . Review of Registered and published studies

  • A Bhasin, M Srivastava, +4 authors B Airan
  • Stem Cells Dev
  • 2013

Similar Papers

Loading similar papers…